Below is an important message from one of our highly valued sponsors. Please read it carefully as they have some special information to share with you.
Dear Reader,
As co-host of The Clay Travis & Buck Sexton Show… one of the most listened-to radio programs in the country… I’ve conducted a lot of important interviews over the years…
But I’ve never done anything like this.
Take a look.
As you’re about to hear… there’s a rapidly developing and massively critical situation quickly unfolding in the Trump Administration right now…
The mainstream media – and very few Americans know anything about this.
But what I believe Trump has up his sleeve could flood an estimated $2.2 trillion into a handful of little-known technology companies over the next decade…
And potentially spark a 40-year economic boom that reshapes this country from the ground up.
I believe this will make history.
I wouldn’t be doing my job if I didn’t come forward and explain what’s happening.
This may be the most important message I’ve ever shared.
Please take a moment to watch my interview now.
You’ll be so glad you did.
Buck Sexton
Former CIA Officer and Co-Host, The Clay & Buck Show
3 Stocks You'll Wish You Bought Before 2026
Submitted by Chris Markoch. Published: 12/3/2025.
Article Highlights
- These three up-and-coming stocks have delivered triple-digit gains in 2025 and continue to show strong momentum.
- Key catalysts—including clinical milestones, revenue acceleration, and consumer demand—suggest more upside ahead.
- Analysts stay optimistic, with price targets suggesting possible double- or triple-digit gains from current levels.
Many investors have profited from the artificial intelligence (AI) trade in 2025. But several up-and-coming stocks in other sectors have also posted impressive gains this year.
The three stocks in this article are still small; the largest market cap is just over $4 billion. However, each has made strong moves and reinforced the idea that time in the market often beats trying to time the market.
Forget AI, This Will Be the Next Big Tech Breakthrough (Ad)
After picking Nvidia in 2016, before it jumped 27,000%...
Jeff Brown is back with what he believes will be the biggest paradigm shift ever.
Yes, even bigger than AI. And he found one Seattle company that's at the center of this new $100 trillion revolution.
Click here to get the name of this company, completely free of charge...
If investors could see the future with absolute clarity, investing would be easy. Unfortunately, the future is rarely clear and a bullish outcome is not guaranteed. Still, the charts speak for themselves: investors who bought these names and had the patience to hold through rough patches are reaping the benefits today — and the rallys may not be finished.
Biotech Breakthrough: A Small Cap With a Big 2026 FDA Catalyst
Celcuity Inc. (NASDAQ: CELC) is a clinical-stage biotechnology company that recently reported positive clinical data for its first-in-class PI3K/mTOR inhibitor targeting HR+/HER2‑negative (hormone receptor–positive, HER2-negative) metastatic breast cancer. The company's pivotal Phase 3 VIKTORIA trial is underway, and some investors believe it could receive U.S. Food & Drug Administration (FDA) approval in 2026.
Investors have been front-running those expectations, pushing CELC stock up more than 660%, with nearly all of those gains occurring since late July. At $99.30 as of this writing, the stock is within about 3% of its consensus price target. Jefferies raised its price target on Dec. 2 to $134 from $108.
The biggest risk is the cost of commercialization. In its most recent earnings report, Celcuity showed a fortified balance sheet with $455 million in cash, cash equivalents, and short-term investments — up about 72% year-over-year (YOY). Management says that should be sufficient until commercialization begins.
Fintech Disruptor Turning Revenue Growth Into Real Momentum
At a time when traditional banks offer less to many consumers, Dave Inc. (NASDAQ: DAVE) makes a compelling case. The Los Angeles-based fintech is best known for the Dave app.
The app provides affordable, transparent financial tools that help users — many living paycheck to paycheck — avoid overdraft fees, budget more effectively, and access short-term cash when needed. The company recently reported a 64% YOY revenue increase and an 85% beat in adjusted earnings per share (EPS).
DAVE stock is up about 120% in 2025, and analysts see more upside. As of this writing the stock trades around $208.24, with a consensus price target of $304.25 — roughly 46% higher.
Some investors may bristle at the company's forward price-to-earnings (P/E) ratio of about 119x. Analysts are forecasting earnings growth of more than 117% over the next 12 months, however, and that pace of growth could justify a higher valuation.
Resale Retail Winner Riding a Massive Consumer Shift
It's been another tough year for consumer staples stocks, but ThredUp Inc. (NASDAQ: TDUP) has been a notable exception. TDUP stock is up more than 430% in 2025, despite a roughly 29% sell-off in the three months ending Dec. 1.
The company operates an online consignment marketplace, which makes it well positioned as many consumer budgets remain stretched. The thrift and resale market was a $49 billion industry in 2024 and is projected to grow to $74 billion by 2029.
TDUP is the smallest of the three names on this list, and short interest above 17% indicates active trading. Still, the company's Q3 report showed strong YOY revenue growth, a record level of new-buyer acquisition, and a 37% YOY increase in orders.
Admittedly, this could be a shorter-term trade. But younger consumers — ThredUp's core market — are likely to remain price-conscious, which helps explain analysts' consensus price target of $12.50, about 68% above its Dec. 1 close.
This email is a sponsored email provided by Paradigm Press, a third-party advertiser of Earnings360 and MarketBeat.
This ad is sent on behalf of Paradigm Press, LLC, at 1001 Cathedral St., Baltimore, MD 21201. If you're not interested in this opportunity from Paradigm Press, LLC, please click here to remove your email from these offers.
If you need help with your subscription, please feel free to contact MarketBeat's U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from Earnings360, you can unsubscribe.
Copyright 2006-2025 MarketBeat Media, LLC. All rights reserved.
345 N Reid Place, Suite 620, Sioux Falls, S.D. 57103-7078. United States..